As of 2024-12-14, the Relative Valuation of Health Catalyst Inc (HCAT) is (53.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.99 USD, the upside of Health Catalyst Inc based on Relative Valuation is -775.5%.
The range of the Relative Valuation is (50.07) - (67.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.8x - 55.9x | 37.8x |
| Forward P/E multiples | 38.5x - 51.8x | 45.2x |
| Fair Price | (50.07) - (67.37) | (53.97) |
| Upside | -726.7% - -943.2% | -775.5% |
| Date | P/E |
| 2024-12-11 | -6.47 |
| 2024-12-10 | -6.44 |
| 2024-12-09 | -6.41 |
| 2024-12-06 | -6.42 |
| 2024-12-05 | -6.34 |
| 2024-12-04 | -6.10 |
| 2024-12-03 | -6.10 |
| 2024-12-02 | -6.94 |
| 2024-11-29 | -6.79 |
| 2024-11-27 | -6.65 |
| 2024-11-26 | -6.54 |
| 2024-11-25 | -6.55 |
| 2024-11-22 | -6.25 |
| 2024-11-21 | -5.89 |
| 2024-11-20 | -5.66 |
| 2024-11-19 | -5.80 |
| 2024-11-18 | -5.79 |
| 2024-11-15 | -5.88 |
| 2024-11-14 | -6.50 |
| 2024-11-13 | -6.66 |
| 2024-11-12 | -6.25 |
| 2024-11-11 | -6.40 |
| 2024-11-08 | -6.34 |
| 2024-11-07 | -6.81 |
| 2024-11-06 | -6.34 |
| 2024-11-05 | -5.97 |
| 2024-11-04 | -5.91 |
| 2024-11-01 | -5.92 |
| 2024-10-31 | -5.97 |
| 2024-10-30 | -6.18 |
| 2024-10-29 | -6.08 |
| 2024-10-28 | -6.10 |
| 2024-10-25 | -5.89 |
| 2024-10-24 | -5.98 |
| 2024-10-23 | -6.21 |
| 2024-10-22 | -6.64 |
| 2024-10-21 | -6.61 |
| 2024-10-18 | -6.66 |
| 2024-10-17 | -6.65 |
| 2024-10-16 | -6.70 |
| 2024-10-15 | -6.55 |
| 2024-10-14 | -6.33 |
| 2024-10-11 | -6.26 |
| 2024-10-10 | -6.04 |
| 2024-10-09 | -6.08 |
| 2024-10-08 | -6.02 |
| 2024-10-07 | -5.86 |
| 2024-10-04 | -5.92 |
| 2024-10-03 | -5.87 |
| 2024-10-02 | -6.07 |